Viswanathan Mohan Selected Research

Prediabetic State (Prediabetes)

1/2022	Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians.
8/2021	Lower Dietary Intake of Plant Protein Is Associated with Genetic Risk of Diabetes-Related Traits in Urban Asian Indian Adults.
1/2021	Prediabetes uncovers differential gene expression at fasting and in response to oral glucose load in immune cells.
3/2020	Prevalence of vitamin D deficiency in urban south Indians with different grades of glucose tolerance.
3/2020	Clinical utility of 30-min plasma glucose for prediction of type 2 diabetes among people with prediabetes: Ancillary analysis of the diabetes community lifestyle improvement program.
2/2019	Dietary changes in a diabetes prevention intervention among people with prediabetes: the Diabetes Community Lifestyle Improvement Program trial.
12/2018	Prevalence of vitamin B12 deficiency in South Indians with different grades of glucose tolerance.
11/2017	The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
9/2017	Effect of lifestyle improvement program on the biomarkers of adiposity, inflammation and gut hormones in overweight/obese Asian Indians with prediabetes.
1/2017	Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Viswanathan Mohan Research Topics

Disease

135	Type 2 Diabetes Mellitus (MODY) 06/2022 - 09/2004
53	Insulin Resistance 01/2022 - 01/2002
34	Glucose Intolerance 01/2022 - 02/2006
27	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 06/2007
26	Obesity 06/2022 - 04/2007
23	Hypertension (High Blood Pressure) 05/2022 - 07/2007
23	Prediabetic State (Prediabetes) 01/2022 - 02/2006
16	Hypoglycemia (Reactive Hypoglycemia) 05/2022 - 11/2009
16	Inflammation (Inflammations) 01/2022 - 10/2010
15	Diabetes Mellitus 05/2022 - 02/2006
15	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2018 - 03/2005
14	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 08/2004
14	Overweight 01/2021 - 03/2009
10	Abdominal Obesity 06/2022 - 03/2009
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 10/2005
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2002
10	Dyslipidemias (Dyslipidemia) 01/2022 - 03/2005
9	Hyperglycemia 03/2022 - 02/2010
9	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2009
9	Body Weight (Weight, Body) 09/2021 - 11/2009
9	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2020 - 12/2014
8	Myocardial Infarction 10/2022 - 03/2002
8	Weight Loss (Weight Reduction) 06/2022 - 03/2002
7	Stroke (Strokes) 10/2022 - 03/2002
7	Diabetes Complications 11/2021 - 03/2002
6	Weight Gain 06/2021 - 08/2010
6	Atherosclerosis 01/2020 - 05/2006
6	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2010
6	Hypertriglyceridemia 08/2015 - 05/2006
5	Neoplasms (Cancer) 01/2022 - 07/2005
5	Infections 03/2021 - 01/2006
5	Mason-Type Diabetes 08/2020 - 10/2005
4	Genetic Risk Score 06/2022 - 01/2019
4	Ketosis 01/2021 - 02/2015
4	Hypercholesterolemia 06/2017 - 07/2007
4	Hypoadiponectinemia 12/2013 - 01/2008
3	Chronic Renal Insufficiency 01/2022 - 10/2010
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2022 - 03/2002
3	Chronic Disease (Chronic Diseases) 01/2022 - 04/2012
3	Vascular Diseases (Vascular Disease) 01/2021 - 06/2009
3	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 01/2013
3	Albuminuria 01/2020 - 07/2015
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 04/2019 - 11/2009
3	Pre-Eclampsia (Preeclampsia) 07/2017 - 07/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2005
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

111	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2002
51	Insulin (Novolin)FDA Link 05/2022 - 01/2002
23	LipidsIBA 10/2022 - 04/2010
23	CholesterolIBA 10/2022 - 08/2004
18	Triglycerides (Triacylglycerol)IBA 09/2021 - 08/2004
17	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 09/2004
17	HDL CholesterolIBA 01/2022 - 04/2005
16	Blood Glucose (Blood Sugar)IBA 10/2022 - 05/2009
14	Retinaldehyde (Retinal)IBA 01/2022 - 09/2004
14	AdiponectinIBA 01/2021 - 04/2005
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2012
9	Hypoglycemic Agents (Hypoglycemics)IBA 06/2022 - 08/2010
9	CytokinesIBA 01/2022 - 01/2009
9	Metformin (Glucophage)FDA LinkGeneric 05/2021 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2005
8	Pharmaceutical PreparationsIBA 01/2022 - 06/2010
8	Insulin Glargine (Lantus)FDA Link 06/2021 - 08/2010
8	Messenger RNA (mRNA)IBA 01/2019 - 09/2007
8	C-Reactive ProteinIBA 08/2015 - 09/2006
7	CreatinineIBA 01/2021 - 09/2004
7	CarbohydratesIBA 11/2018 - 05/2009
6	C-PeptideIBA 01/2022 - 08/2013
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2006
6	AlbuminsIBA 01/2022 - 08/2007
6	LDL CholesterolIBA 01/2021 - 06/2007
6	EnzymesIBA 11/2019 - 09/2007
6	AdipokinesIBA 01/2019 - 04/2007
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 09/2006
4	oxidized low density lipoproteinIBA 05/2022 - 02/2007
4	HDL LipoproteinsIBA 09/2016 - 04/2005
4	Thiobarbituric Acid Reactive SubstancesIBA 06/2012 - 09/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 05/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 10/2017
3	Biological ProductsIBA 01/2022 - 10/2010
3	Transcription Factors (Transcription Factor)IBA 08/2021 - 09/2007
3	insulin aspart protamine drug combination 30:70 insulin aspartIBA 06/2021 - 03/2018
3	VildagliptinIBA 05/2021 - 01/2017
3	SodiumIBA 01/2020 - 05/2016
3	Ramipril (Altace)FDA LinkGeneric 01/2020 - 06/2009
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 05/2010
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019 - 09/2014
3	FatsIBA 11/2018 - 10/2017
3	Indicators and Reagents (Reagents)IBA 01/2017 - 07/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 02/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016 - 06/2009
3	ImmunosorbentsIBA 03/2015 - 06/2009
3	2,4-thiazolidinedione (thiazolidinedione)IBA 02/2013 - 06/2009
3	Rosiglitazone (Avandia)FDA Link 02/2013 - 06/2009
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2022 - 05/2006

Therapy/Procedure

30	Therapeutics 05/2022 - 11/2009
26	Glycemic Control 06/2022 - 01/2009
4	Surgical Instruments (Clip) 02/2019 - 04/2012
3	Bariatric Surgery 01/2022 - 11/2020
3	Cesarean Section (Caesarean Section) 07/2017 - 07/2016